Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Patrick G. Enright currently holds 5,882 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrick G. Enright has been a net seller of JAZZ stock. They have purchased $84.0M and sold $363.7M worth of shares.
Patrick G. Enright's most recent insider trade was on Dec 11, 2025, when they purchased 5,882 shares at $42.50 per share.
Patrick G. Enright serves as Executive at Jazz Pharmaceuticals plc (JAZZ). They have executed 410 insider transactions totaling $447.6M over their tenure at the company.
Patrick G. Enright holds the position of Executive at Jazz Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Patrick G. Enright has shown a selling trading pattern, with $84.0M in total purchases and $363.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Patrick G. Enright was on Feb 6, 2023, when they purchased $12.0M worth of VERA shares. This transaction involved 1,714,285 shares at $7.00 per share.
Patrick G. Enright currently owns 5,882 shares of Jazz Pharmaceuticals plc (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Patrick G. Enright's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Patrick G. Enright has 410 Form 4 filings on record as an insider at Jazz Pharmaceuticals plc.
Set alerts for Patrick G. Enright and 40,000+ other insiders.